Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Purpose
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Condition
- Breast Cancer
Eligibility
- Eligible Ages
- Over 35 Years
- Eligible Genders
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Patients must be women with newly diagnosed histologically proven invasive carcinoma of the breast with no evidence of metastases, staged as per site standard of care. - Patients must have been treated by BCS or mastectomy with clear margins of excision. Post-mastectomy positive margins for invasive disease and/or DCIS is not allowed. Multifocal disease (i.e. the presence of two or more foci or breast cancer within the same breast quadrant) and multicentric disease (i.e. the presence of two or more foci of breast cancer in different quadrants of the same breast) are allowed. - Patients with T3N0 disease are eligible. - Patients with disease limited to nodal micrometastases are eligible - Patients with nodal macrometastases (>2mm) treated by axillary dissection must have 1-3 positive axillary nodes (macrometastases, > 2 mm). - Patients treated by mastectomy and SLNB alone must have only 1-2 positive axillary nodes (macrometastases, > 2 mm). - Patients must be ER ≥ 1% and HER2 negative on local testing - Patients must have an Oncotype DX recurrence score ≤25 obtained from testing of breast tumour tissue from a core biopsy or from the surgical specimen. - Patient must consent to provision of, and investigator(s) must agree to submit to the CCTG Central Tumour Bank, a representative formalin fixed paraffin block of tumour tissue in order that the specific correlative marker assays described in the protocol may be conducted - Patient must consent to provision of samples of blood in order that the specific correlative marker assays described in the protocol may be conducted. - Patients must have had endocrine therapy initiated or planned for ≥ 5 years. Premenopausal women will receive ovarian ablation plus aromatase inhibitor therapy or tamoxifen if adjuvant chemotherapy was not administered. For all patients, endocrine therapy can be given concurrently or following RT. - Patients may or may not have had adjuvant chemotherapy. - RT must commence within 16 weeks of definitive surgery if the patient is not treated with chemotherapy. If adjuvant chemotherapy is given, RT must begin within 12 weeks after the last dose. (Note: adjuvant chemotherapy may be ongoing at the time of randomization). Definitive surgery is defined as the last breast cancer-related surgery. - Patient's ECOG performance status must be 0, 1 or 2. - Patient's age must be ≥ 35 years. - For the first 736 eligible English or French-speaking subjects who have agreed to optional questionnaire completion: Patient is able (i.e. sufficiently fluent) and willing to complete the quality of life, health utilities and lost productivity questionnaires in either English or French (note: enrollment completed 2022Aug02) - Patient consent must be appropriately obtained in accordance with applicable local and regulatory requirements - Patients must be accessible for treatment and follow-up. Investigators must assure themselves the patients randomized on this trial will be available for complete documentation of the treatment, adverse events, and follow-up. - In accordance with CCTG policy, protocol treatment is to begin within 6 weeks of patient randomization. - Women of childbearing potential must have agreed to use an effective contraceptive method. A woman is considered to be of "childbearing potential" if she has had menses at any time in the preceding 12 consecutive months.
Exclusion Criteria
- Patients with nodal disease limited to isolated tumour cells (pN0i+ < 0.2 mm). - Patients with pT3N1 and pT4 disease (Note: patients with T3N0 are eligible). - Any prior history, not including the index cancer, of ipsilateral invasive breast cancer or ipsilateral DCIS treated with radiation therapy. (Patients with synchronous or previous ipsilateral LCIS are eligible.) - Synchronous or previous contralateral invasive breast cancer. (Patients with contralateral DCIS are eligible unless previously treated with radiation.) - History of non-breast malignancies except adequately treated non-melanoma skin cancers, in situ cancers treated by local excision or other cancers curatively treated with no evidence of disease for ≥ 5 years. - Patients who are pregnant. - Patients that have had prior ipsilateral chestwall/thoracic radiation. - Patients treated with chemo or endocrine therapy administered in the neoadjuvant setting for breast cancer. Endocrine therapy exposure 12 weeks or less prior to surgery is permitted. - Patients with serious non-malignant disease (e.g. cardiovascular, scleroderma etc.) which would preclude RT. - Patients with any serious active or co-morbid medical conditions, laboratory abnormality, psychiatric illness, active or uncontrolled infections, or serious illnesses or medical conditions that would prevent the patient from participating or to be managed according to the protocol (according to investigator's decision).
Study Design
- Phase
- Phase 3
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Active Comparator No Regional Radiotherapy |
A. Whole Breast Irradiation (WBI) following BCS or; B. No Radiotherapy (RT) following mastectomy |
|
Active Comparator Regional Radiotherapy |
A. WBI plus RT to the regional nodes (supraclavicular, non-dissected axillary, and internal mammary) following BCS or; B. RT to the chestwall and regional nodes (supraclavicular, non-dissected axillary, and internal mammary) following mastectomy |
|
Recruiting Locations
Fairbanks, Alaska 99701
Tucson, Arizona 85704
Site Public Contact
520-694-8900
Tucson, Arizona 85719
Anaheim, California 92806
Dublin, California 94568
Site Public Contact
877-642-4691
Fresno, California 93720
Los Angeles, California 90027
Los Angeles, California 90033
Los Angeles, California 90033
Site Public Contact
323-865-0451
Napa, California 94558
Site Public Contact
707-521-3830
Oakland, California 94611
Orange, California 92868
Site Public Contact
714-734-6220
Orange, California 92868
Palm Springs, California 92262
Site Public Contact
760-416-4730
Rancho Cordova, California 95670
Rohnert Park, California 94928
Roseville, California 95678
Sacramento, California 95816
Saint Helena, California 94574
Site Public Contact
707-967-3698
Santa Clara, California 95051
Santa Monica, California 90404
Site Public Contact
310-582-7448
South San Francisco, California 94080
Aurora, Colorado 80045
Site Public Contact
720-848-0650
Boulder, Colorado 80304
Colorado Springs, Colorado 80907
Colorado Springs, Colorado 80909
Site Public Contact
719-365-2406
Colorado Springs, Colorado 80920
Site Public Contact
719-364-6700
Colorado Springs, Colorado 80923
Denver, Colorado 80206
Fort Collins, Colorado 80524
Site Public Contact
970-297-6150
Golden, Colorado 80401
Greeley, Colorado 80631
Greeley, Colorado 80631
Highlands Ranch, Colorado 80129
Site Public Contact
720-848-0650
Loveland, Colorado 80539
Wheat Ridge, Colorado 80033
Norwalk, Connecticut 06856
Washington, District of Columbia 20010
Site Public Contact
202-877-8839
Washington, District of Columbia 20016
Boca Raton, Florida 33486
Site Public Contact
561-955-4800
Clearwater, Florida 33756
Site Public Contact
855-314-8646
Coral Gables, Florida 33146
Site Public Contact
305-243-2647
Deerfield Beach, Florida 33442
Site Public Contact
305-243-2647
Hollywood, Florida 33021
Jacksonville, Florida 32224-9980
Site Public Contact
855-776-0015
Miami, Florida 33136
Site Public Contact
305-243-2647
Miami, Florida 33176
Site Public Contact
786-596-2000
Pembroke Pines, Florida 33028
Site Public Contact
954-265-4325
Plantation, Florida 33324
Site Public Contact
954-837-1490
Saint Petersburg, Florida 33705
Tampa, Florida 33607
Tampa, Florida 33612
Weston, Florida 33331
Savannah, Georgia 31405
Boise, Idaho 83706
Coeur d'Alene, Idaho 83814
Post Falls, Idaho 83854
Chicago, Illinois 60611
Chicago, Illinois 60612
Chicago, Illinois 60625
Site Public Contact
773-878-8200
Chicago, Illinois 60637
Decatur, Illinois 62526
DeKalb, Illinois 60115
Effingham, Illinois 62401
Evanston, Illinois 60201
Site Public Contact
847-570-2109
Geneva, Illinois 60134
Glenview, Illinois 60026
Site Public Contact
847-570-2109
Highland Park, Illinois 60035
Site Public Contact
847-570-2109
Lake Forest, Illinois 60045
Maywood, Illinois 60153
Site Public Contact
708-226-4357
New Lenox, Illinois 60451
Orland Park, Illinois 60462
Park Ridge, Illinois 60068
Site Public Contact
847-384-3621
Peoria, Illinois 61637
Rockford, Illinois 61114
Springfield, Illinois 62781
Urbana, Illinois 61801
Warrenville, Illinois 60555
Avon, Indiana 46123
Carmel, Indiana 46032
Fishers, Indiana 46037
Site Public Contact
317-356-2422
Indianapolis, Indiana 46202
Indianapolis, Indiana 46202
Indianapolis, Indiana 46219
Indianapolis, Indiana 46227
Indianapolis, Indiana 46256
Muncie, Indiana 47303
Site Public Contact
765-751-5850
Cedar Rapids, Iowa 52402
Clive, Iowa 50325
Creston, Iowa 50801
Des Moines, Iowa 50309
Site Public Contact
515-241-6727
Des Moines, Iowa 50314
Kansas City, Kansas 66160
Overland Park, Kansas 66210
Wichita, Kansas 67214
Edgewood, Kentucky 41017
Fort Thomas, Kentucky 41075
Lexington, Kentucky 40504
Louisville, Kentucky 40202
Site Public Contact
502-562-3429
Shreveport, Louisiana 71103
Bath, Maine 04530
Brewer, Maine 04412
Site Public Contact
800-987-3005
Portland, Maine 04102
Site Public Contact
207-885-7565
Sanford, Maine 04073
Site Public Contact
207-459-1600
Scarborough, Maine 04074
Annapolis, Maryland 21401
Baltimore, Maryland 21201
Site Public Contact
800-888-8823
Baltimore, Maryland 21204
Site Public Contact
443-849-3706
Baltimore, Maryland 21229
Site Public Contact
410-368-2910
Baltimore, Maryland 21237
Site Public Contact
443-777-7364
Baltimore, Maryland 21239
Baltimore, Maryland 21287
Bethesda, Maryland 20814
Easton, Maryland 21601
Glen Burnie, Maryland 21061
Site Public Contact
410-553-8100
Towson, Maryland 21204
Boston, Massachusetts 02215
Site Public Contact
617-667-9925
Lowell, Massachusetts 01854
Springfield, Massachusetts 01199
Ann Arbor, Michigan 48109
Site Public Contact
800-865-1125
Bay City, Michigan 48706
Clarkston, Michigan 48346
Dearborn, Michigan 48124
Site Public Contact
248-551-7695
Farmington Hills, Michigan 48336
Site Public Contact
248-551-7695
Flint, Michigan 48532
Grand Rapids, Michigan 49503
Grand Rapids, Michigan 49503
Kalamazoo, Michigan 49007
Lansing, Michigan 48910
Mount Clemens, Michigan 48043
Muskegon, Michigan 49444
Novi, Michigan 48374
Petoskey, Michigan 49770
Port Huron, Michigan 48060
Royal Oak, Michigan 48073
Site Public Contact
248-551-7695
Southfield, Michigan 48075
Traverse City, Michigan 49684
Troy, Michigan 48085
Site Public Contact
248-551-7695
Wyoming, Michigan 49519
Bemidji, Minnesota 56601
Minneapolis, Minnesota 55407
Minneapolis, Minnesota 55415
Southhaven, Mississippi 38671
Cape Girardeau, Missouri 63703
Columbia, Missouri 65212
Site Public Contact
573-882-7440
Kansas City, Missouri 64154
Lee's Summit, Missouri 64064
Saint Louis, Missouri 63131
Site Public Contact
314-996-5569
Billings, Montana 59101
Great Falls, Montana 59405
Omaha, Nebraska 68124
Concord, New Hampshire 03301
Site Public Contact
603-224-2556
Exeter, New Hampshire 03833
Site Public Contact
800-439-3837
Lebanon, New Hampshire 03756
Manchester, New Hampshire 03103
Site Public Contact
800-339-6484
Basking Ridge, New Jersey 07920
Site Public Contact
212-639-7592
Middletown, New Jersey 07748
Site Public Contact
212-639-7592
Montvale, New Jersey 07645
Site Public Contact
212-639-7592
New Brunswick, New Jersey 08901
Albuquerque, New Mexico 87102
Albuquerque, New Mexico 87109
Albuquerque, New Mexico 87109
Las Cruces, New Mexico 88011
Bronx, New York 10461
Bronx, New York 10467
Brooklyn, New York 11215
Brooklyn, New York 11219
Site Public Contact
718-765-2500
Canandaigua, New York 14424
Site Public Contact
585-396-6161
Commack, New York 11725
Site Public Contact
212-639-7592
Cooperstown, New York 13326
Dansville, New York 14437
Harrison, New York 10604
Site Public Contact
212-639-7592
Mineola, New York 11501
New York, New York 10003
New York, New York 10011
New York, New York 10016
New York, New York 10029
New York, New York 10032
New York, New York 10065
Site Public Contact
212-639-7592
Rochester, New York 14606
Site Public Contact
585-758-7877
Rochester, New York 14620
Site Public Contact
585-341-8113
Rochester, New York 14621
Rochester, New York 14623
Rochester, New York 14642
Site Public Contact
585-275-5830
Stony Brook, New York 11794
Site Public Contact
800-862-2215
Syracuse, New York 13210
Site Public Contact
315-464-5476
Uniondale, New York 11553
Site Public Contact
212-639-7592
Webster, New York 14580
Chapel Hill, North Carolina 27599
Gastonia, North Carolina 28054
Hendersonville, North Carolina 28791
Bismarck, North Dakota 58501
Grand Forks, North Dakota 58201
Site Public Contact
701-780-6520
Akron, Ohio 44307
Avon, Ohio 44011
Site Public Contact
800-641-2422
Beachwood, Ohio 44122
Canton, Ohio 44708
Site Public Contact
888-293-4673
Canton, Ohio 44710
Chardon, Ohio 44024
Cleveland, Ohio 44106
Cleveland, Ohio 44109
Columbus, Ohio 43210
Columbus, Ohio 43214
Columbus, Ohio 43215
Columbus, Ohio 43219
Delaware, Ohio 43015
Dublin, Ohio 43016
Grove City, Ohio 43123
Mentor, Ohio 44060
Middleburg Heights, Ohio 44130
Parma, Ohio 44129
Perrysburg, Ohio 43551
Ravenna, Ohio 44266
Sandusky, Ohio 44870
Sylvania, Ohio 43560
Wadsworth, Ohio 44281
Westerville, Ohio 43081
Westlake, Ohio 44145
Westlake, Ohio 44145
Oklahoma City, Oklahoma 73104
Bend, Oregon 97701
Bryn Mawr, Pennsylvania 19010
Carlisle, Pennsylvania 17015
Erie, Pennsylvania 16505
Erie, Pennsylvania 16544
Site Public Contact
814-452-5000
Farrell, Pennsylvania 16121
Greensburg, Pennsylvania 15601
Site Public Contact
724-838-1900
Harrisburg, Pennsylvania 17109
Hershey, Pennsylvania 17033-0850
Indiana, Pennsylvania 15701
Jefferson Hills, Pennsylvania 15025
Lancaster, Pennsylvania 17601
Site Public Contact
717-544-0511
Lancaster, Pennsylvania 17602
Site Public Contact
717-544-5511
Mechanicsburg, Pennsylvania 17050
Media, Pennsylvania 19063
Monroeville, Pennsylvania 15146
Site Public Contact
412-858-7746
Monroeville, Pennsylvania 15146
Paoli, Pennsylvania 19301
Philadelphia, Pennsylvania 19107
Philadelphia, Pennsylvania 19114
Pittsburgh, Pennsylvania 15212
Site Public Contact
877-284-2000
Pittsburgh, Pennsylvania 15213
Site Public Contact
412-647-2811
Pittsburgh, Pennsylvania 15215
Site Public Contact
412-784-4900
Pittsburgh, Pennsylvania 15224
Site Public Contact
412-578-5000
Pittsburgh, Pennsylvania 15232
Site Public Contact
412-621-2334
Pittsburgh, Pennsylvania 15237
Site Public Contact
412-367-6454
Pittsburgh, Pennsylvania 15243
Site Public Contact
412-502-3920
Reading, Pennsylvania 19605
Washington, Pennsylvania 15301
West Reading, Pennsylvania 19611
Site Public Contact
610-988-9323
Wexford, Pennsylvania 15090
Willow Grove, Pennsylvania 19090
Wynnewood, Pennsylvania 19096
York, Pennsylvania 17408
Site Public Contact
717-724-6760
Providence, Rhode Island 02905
Site Public Contact
401-274-1122
Warwick, Rhode Island 02886
Site Public Contact
401-737-7010
Bluffton, South Carolina 29910
Charleston, South Carolina 29425
Greenville, South Carolina 29607
Greenwood, South Carolina 29646
Hilton Head Island, South Carolina 29926
Spartanburg, South Carolina 29303
Sioux Falls, South Dakota 57117-5134
Memphis, Tennessee 38120
Baytown, Texas 77521
Conroe, Texas 77384
Dallas, Texas 75235
Dallas, Texas 75390
Galveston, Texas 77555-0565
Houston, Texas 77030
Houston, Texas 77030
Site Public Contact
713-790-2700
Houston, Texas 77030
Houston, Texas 77070
Houston, Texas 77079
Houston, Texas 77094
Site Public Contact
832-522-2873
League City, Texas 77573
Nassau Bay, Texas 77058
San Antonio, Texas 78229
Sugar Land, Texas 77478
Sugar Land, Texas 77479
Site Public Contact
281-242-2873
The Woodlands, Texas 77385
American Fork, Utah 84003
Cedar City, Utah 84720
Farmington, Utah 84025
Logan, Utah 84321
Murray, Utah 84107
Ogden, Utah 84403
Provo, Utah 84604
Riverton, Utah 84065
Saint George, Utah 84770
Salt Lake City, Utah 84106
Salt Lake City, Utah 84112
Salt Lake City, Utah 84143
South Jordan, Utah 84009
Berlin, Vermont 05602
Site Public Contact
802-225-5400
Burlington, Vermont 05401
Saint Johnsbury, Vermont 05819
Portsmouth, Virginia 23708-2197
Site Public Contact
757-953-5939
Auburn, Washington 98001
Gig Harbor, Washington 98335
Seattle, Washington 98122
Tacoma, Washington 98405
Morgantown, West Virginia 26506
Antigo, Wisconsin 54409
Eau Claire, Wisconsin 54701
Eau Claire, Wisconsin 54701
Grafton, Wisconsin 53024
Green Bay, Wisconsin 54301
Site Public Contact
920-435-8326
Green Bay, Wisconsin 54301
Green Bay, Wisconsin 54303
Green Bay, Wisconsin 54311
Johnson Creek, Wisconsin 53038
Kenosha, Wisconsin 53142
La Crosse, Wisconsin 54601
Madison, Wisconsin 53792
Marinette, Wisconsin 54143
Marshfield, Wisconsin 54449
Menomonee Falls, Wisconsin 53051
Site Public Contact
262-257-5100
Milwaukee, Wisconsin 53215
Milwaukee, Wisconsin 53226
Site Public Contact
414-805-3666
Milwaukee, Wisconsin 53233
Minocqua, Wisconsin 54548
Mukwonago, Wisconsin 53149
New Richmond, Wisconsin 54017
Oak Creek, Wisconsin 53154
Site Public Contact
414-805-0505
Oconomowoc, Wisconsin 53066
Site Public Contact
262-928-7878
Oshkosh, Wisconsin 54904
Rice Lake, Wisconsin 54868
Sheboygan, Wisconsin 53081
Sheboygan, Wisconsin 53081
Stevens Point, Wisconsin 54482
Sturgeon Bay, Wisconsin 54235-1495
Summit, Wisconsin 53066
Two Rivers, Wisconsin 54241
Wausau, Wisconsin 54401
Site Public Contact
877-405-6866
West Allis, Wisconsin 53227
West Bend, Wisconsin 53095
Site Public Contact
414-805-0505
Weston, Wisconsin 54476
Weston, Wisconsin 54476
Wisconsin Rapids, Wisconsin 54494
Site Public Contact
715-422-7718
More Details
- NCT ID
- NCT03488693
- Status
- Recruiting
- Sponsor
- Canadian Cancer Trials Group
Detailed Description
Women with node positive breast cancer normally will receive endocrine therapy and some may receive chemotherapy to help prevent the cancer from coming back. Many women will also receive radiotherapy to the whole breast/chest area and the surrounding lymph glands (called regional radiotherapy). No one really knows whether patients with low risk breast cancer need to receive regional radiotherapy. Some women may be getting regional radiotherapy who do not need it. These women may be exposed to the side effects of their treatment without benefit.